Bowhead Specialty Holdings Inc.’s (NYSE:BOW) Quiet Period Set To End on July 2nd

Bowhead Specialty’s (NYSE:BOW) quiet period will expire on Tuesday, July 2nd. Bowhead Specialty had issued 7,529,412 shares in its public offering on May 23rd. The total size of the offering was $128,000,004 based on an initial share price of $17.00. During Bowhead Specialty’s quiet period, insiders and underwriters involved in the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Analyst Ratings Changes

A number of equities analysts recently weighed in on BOW shares. Royal Bank of Canada started coverage on shares of Bowhead Specialty in a research report on Monday, June 17th. They set an “outperform” rating and a $32.00 price objective for the company. Morgan Stanley began coverage on Bowhead Specialty in a research note on Monday, June 17th. They set an “equal weight” rating and a $26.00 target price on the stock. Keefe, Bruyette & Woods started coverage on Bowhead Specialty in a research report on Monday, June 17th. They issued a “market perform” rating and a $30.00 target price for the company. JMP Securities began coverage on shares of Bowhead Specialty in a research note on Monday, June 17th. They issued an “outperform” rating and a $31.00 price objective for the company. Finally, JPMorgan Chase & Co. assumed coverage on shares of Bowhead Specialty in a report on Monday, June 17th. They set a “neutral” rating and a $27.00 target price on the stock. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $29.20.

Bowhead Specialty Stock Performance

Shares of BOW opened at $25.34 on Friday. Bowhead Specialty has a 1 year low of $22.14 and a 1 year high of $27.49.

Insider Buying and Selling

In other news, insider David John Newman acquired 26,815 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were bought at an average cost of $20.36 per share, with a total value of $545,953.40. Following the transaction, the insider now owns 49,344 shares in the company, valued at approximately $1,004,643.84. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Bowhead Specialty news, insider David John Newman acquired 26,815 shares of the stock in a transaction dated Tuesday, May 28th. The stock was acquired at an average cost of $20.36 per share, with a total value of $545,953.40. Following the transaction, the insider now owns 49,344 shares in the company, valued at approximately $1,004,643.84. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Shirley Shek Li Yap bought 3,200 shares of the business’s stock in a transaction dated Tuesday, May 28th. The shares were acquired at an average cost of $17.00 per share, for a total transaction of $54,400.00. Following the transaction, the chief accounting officer now directly owns 14,964 shares in the company, valued at approximately $254,388. The disclosure for this purchase can be found here. Insiders bought 100,839 shares of company stock worth $1,804,361 over the last 90 days.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.